Edmund F. Mrak

FDA investigator

Appears on 30 documents from 2010 to 2026, most often at sites in New York. Most often cites design and construction features (21 CFR 211.42).

30
Documents on file
5.7
Observations per 483
2010
First seen
2026
Most recent

What they cite most

From 170 observations

Activity by year

2010: 1, 2014: 1, 2015: 1, 2016: 1, 2017: 1, 2018: 3, 2019: 2, 2020: 3, 2021: 1, 2022: 6, 2023: 5, 2024: 4, 2026: 1

Where

New York 7 · Vermont 5 · Maine 3 · Maryland 3 · New Jersey 3 · Connecticut 2

Is Edmund F. Mrak coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

30 documents, newest first
FirmOpen
483 Perrigo New York, Inc.May 8, 2026 · Bronx, New York
483 Hikma Injectables USA Inc.Jun 25, 2024 · Dayton, New Jersey
483 American Regent, Inc.Apr 24, 2024 · Shirley, New York
483 Bell-More Labs, IncApr 3, 2024 · Hampstead, Maryland
483 Juno Pharma Canada Inc.Jan 17, 2024 · Montreal, Canada
483 University Instrumentation Center at UNHDec 5, 2023 · Durham, New Hampshire
483 SEAWAY PHARMASep 21, 2023 · Massena, New York

About this profile

What does Edmund F. Mrak inspect?

Edmund F. Mrak appears on 30 documents on file covering 26 sites, most often in New York.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Edmund F. Mrak is dated May 8, 2026.